$1.0 Billion
Avantor, Inc.
Convertible Offering
Active Bookrunner
$287.5 Million
Teladoc, Inc.
Convertible Offering
Passive Bookrunner
$125.0 Million
Vocera Communication, Inc.
Convertible Offering
Active Bookrunner
$46.0 Million
OptiNose AS
Confidentially Marketed Follow-On Offering
Left Bookrunner
$75.0 Million
CymaBay Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$101.2 Million
Repare Therapeutics Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.5 Million
ViewRay Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$85.0 Million
Sutro Biopharma, Inc.
Initial Public Offering
Active Bookrunner
$75.0 Million
Apollo Endosurgery, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$86.3 Million
aTyr_New
aTyr Pharma Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Subscribe to United States

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.